Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 4
1993 2
1994 5
1995 3
1996 3
1997 4
1998 4
1999 5
2000 8
2001 8
2002 28
2003 28
2004 30
2005 64
2006 87
2007 106
2008 123
2009 135
2010 172
2011 196
2012 273
2013 250
2014 234
2015 206
2016 241
2017 208
2018 200
2019 111
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

2,395 results
Results by year
Filters applied: . Clear all
Page 1
Exenatide modulates visual cortex responses.
Binda P, Eldor R, Huerta C, Adams J, Lancaster J, Fox P, Del Prato S, DeFronzo R, Abdul-Ghani M, Daniele G. Binda P, et al. Version 2. Diabetes Metab Res Rev. 2019 Sep;35(6):e3167. doi: 10.1002/dmrr.3167. Epub 2019 May 6. Diabetes Metab Res Rev. 2019. PMID: 30974038 Free PMC article.
The efficacy and safety of exenatide once weekly in patients with type 2 diabetes.
Heimbürger SM, Brønden A, Johansen NJ, Dejgaard TF, Vilsbøll T, Knop FK. Heimbürger SM, et al. Expert Opin Pharmacother. 2019 Apr;20(5):501-510. doi: 10.1080/14656566.2019.1571040. Epub 2019 Feb 7. Expert Opin Pharmacother. 2019. PMID: 30730773 Review.
Prehospital exenatide in hyperglycemic stroke-A randomized trial.
Larsson M, Castrén M, Lindström V, von Euler M, Patrone C, Wahlgren N, Nathanson D. Larsson M, et al. Acta Neurol Scand. 2019 Dec;140(6):443-448. doi: 10.1111/ane.13166. Epub 2019 Oct 2. Acta Neurol Scand. 2019. PMID: 31518433 Clinical Trial.
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K, Hibbert S, Budnik N, Zampedri L, Dickson J, Li Y, Aviles-Olmos I, Warner TT, Limousin P, Lees AJ, Greig NH, Tebbs S, Foltynie T. Athauda D, et al. Lancet. 2017 Oct 7;390(10103):1664-1675. doi: 10.1016/S0140-6736(17)31585-4. Epub 2017 Aug 3. Lancet. 2017. PMID: 28781108 Free PMC article. Clinical Trial.
Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly alone, or dapagliflozin alone added to metformin monotherapy in subgroups of patients with type 2 diabetes in the DURATION-8 randomized controlled trial.
Frías JP, Hardy E, Ahmed A, Öhman P, Jabbour S, Wang H, Guja C. Frías JP, et al. Diabetes Obes Metab. 2018 Jun;20(6):1520-1525. doi: 10.1111/dom.13296. Epub 2018 Apr 19. Diabetes Obes Metab. 2018. PMID: 29573139 Free PMC article. Clinical Trial.
Impact of intravenous exenatide infusion for perioperative blood glucose control on myocardial ischemia-reperfusion injuries after coronary artery bypass graft surgery: sub study of the phase II/III ExSTRESS randomized trial.
Besch G, Perrotti A, Salomon du Mont L, Puyraveau M, Ben-Said X, Baltres M, Barrucand B, Flicoteaux G, Vettoretti L, Samain E, Chocron S, Pili-Floury S. Besch G, et al. Cardiovasc Diabetol. 2018 Nov 1;17(1):140. doi: 10.1186/s12933-018-0784-y. Cardiovasc Diabetol. 2018. PMID: 30384842 Free PMC article. Clinical Trial.
Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin, added to metformin monotherapy, on body weight, systolic blood pressure, and triglycerides in patients with type 2 diabetes in the DURATION-8 study.
Jabbour SA, Frías JP, Guja C, Hardy E, Ahmed A, Öhman P. Jabbour SA, et al. Diabetes Obes Metab. 2018 Jun;20(6):1515-1519. doi: 10.1111/dom.13206. Epub 2018 Feb 4. Diabetes Obes Metab. 2018. PMID: 29316164 Free PMC article. Clinical Trial.
2,395 results
Jump to page
Feedback